Search clinical trials for: placebo lapatinib capecitabine
Total 56389 results
-
Tragara Pharmaceuticals, Inc.Terminated
-
Huazhong University of Science and TechnologyUnknown
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
GlaxoSmithKlineCompleted
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, ColorectalUnited States
-
Cancer Trials IrelandCompletedPancreatic CancerIreland
-
UNICANCERGlaxoSmithKlineCompletedMetastatic Breast Cancer | 70 Years Old Patients and Over | After One Line of Chemotherapy With TrastuzumabFrance
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Queens Cancer Center of Queens HospitalCompletedMetastatic Breast Cancer | Central Nervous System (CNS) MetastasesUnited States
-
GlaxoSmithKlineCompletedNeoplasms, Gastrointestinal TractTaiwan, Korea, Republic of, United States, Canada, Russian Federation, Mexico
-
National Center for Tumor Diseases, HeidelbergTerminatedGastroEsophageal CancerGermany
-
Hebei Medical UniversityUnknownGastroesophageal Junction AdenocarcinomaChina
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHead and Neck Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastHong Kong, China
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
Georgetown UniversityGlaxoSmithKlineTerminatedPancreas CancerUnited States
-
Bio-Thera SolutionsUnknownHER2-positive Advanced Breast CancerChina
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
Tianjin Hemay Pharmaceutical Co., LtdRecruiting
-
UNICANCERCompletedBreast Cancer | Metastatic CancerFrance
-
Xin-Hua XuUnknownHepatocellular CarcinomaChina
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Centre Jean PerrinTerminatedColorectal Cancer | Metastatic Breast CancerFrance
-
Yanqiao ZhangUnknownMetastatic Colorectal Cancer
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
-
University of Wisconsin, MadisonGlaxoSmithKlineCompletedMetastatic Colorectal CancerUnited States
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruitingProgression-free Survival;Progression-free Survival;Disease Control Rate; SafetyChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownTriple-negative Breast CancerChina
-
Beijing Friendship HospitalCompletedCamrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.Biliary Tract Cancer | Capecitabine | Targeted Molecular Therapy | Anti-PD-1 TherapyChina
-
GlaxoSmithKlineCompletedCancerUnited States
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Brazil, Colombia, Peru
-
Li HuipingNot yet recruiting
-
Hebei Medical UniversityUnknownGastroesophageal Junction AdenocarcinomaChina
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Novartis PharmaceuticalsActive, not recruitingNeoplasms, Gastrointestinal TractChina, Canada, Estonia, Italy, Turkey, Argentina, Israel, Netherlands, Poland, Russian Federation, Thailand, Brazil, Chile, Hong Kong, Hungary, India, Mexico, Peru, Taiwan, Ukraine, United States, Korea, Republic of, Puerto Rico
-
Zhongshan Hospital Xiamen UniversityUnknownHepatic Metastasis of Colorectal CancerChina
-
European Organisation for Research and Treatment...TerminatedGastric Cancer | Adenocarcinoma of the Gastroesophageal JunctionBelgium, Portugal, Germany